idarubicin has been researched along with ATLL in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bee, PC; Gan, GG; Goh, KY; Sangkar, JV; Teh, A | 1 |
| Escherich, G; Hassenpflug, WA; Horstmann, MA; Janka, G; Kabisch, H; zur Stadt, U | 1 |
| Baccarani, M; Damiani, D; Lauria, F; Michelutti, A; Michieli, M; Pipan, C; Raspadori, D | 1 |
| Baccarani, M; Cerno, M; Damiani, D; Melli, C; Michelutti, A; Michieli, M | 1 |
| Allen, PD; Kelsey, SM; Newland, AC; Richardson, DS | 2 |
| Barbui, T; Bassan, R; Chiodini, B | 1 |
| Barbui, T; Bassan, R; Casula, P; Corneo, G; Coser, P; Fabris, P; Izzi, T; Lambertenghi-Deliliers, G; Lerede, T; Morandi, S; Pogliani, E; Rossi, G; Vespignani, M | 1 |
| Achtari, C; Hohlfeld, P | 1 |
| Jia, L; Kelsey, SM; Liu, FT; Newland, AC | 1 |
1 trial(s) available for idarubicin and ATLL
| Article | Year |
|---|---|
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinic
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Female; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine | 1999 |
9 other study(ies) available for idarubicin and ATLL
| Article | Year |
|---|---|
A case of T-cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia.
Topics: Adolescent; Cytogenetic Analysis; Family Health; Fatal Outcome; Female; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Opportunistic Infections; Siblings; Tretinoin | 2004 |
Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Drug Evaluation; Drug Synergism; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Leukemia-Lymphoma, Adult T-Cell; Male; Methylprednisolone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recombinant Proteins; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thiotepa; Topotecan; Treatment Outcome; Vidarabine; Vinblastine | 2005 |
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Gene Expression; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured | 1993 |
D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Survival; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Verapamil | 1993 |
Inhibition of FAS/FAS-ligand does not block chemotherapy-induced apoptosis in drug sensitive and resistant cells.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Cycle; Clone Cells; Drug Resistance, Multiple; Etoposide; Fas Ligand Protein; fas Receptor; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
Effects of PARP inhibition on drug and Fas-induced apoptosis in leukaemic cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; fas Receptor; Genes, MDR; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Microtubules; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
Apoptosis by anthracyclines at therapeutic concentrations in MDR1+ human leukemic cells.
Topics: Annexin A5; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Genes, MDR; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Lipids; Necrosis; Phosphatidylserines; Tumor Cells, Cultured | 1999 |
Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy.
Topics: Adult; Antibiotics, Antineoplastic; Female; Heart; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Placenta; Pregnancy; Pregnancy Trimester, Second | 2000 |
Generation of reactive oxygen species is not involved in idarubicin-induced apoptosis in human leukaemic cells.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cell Death; Cell Line; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Potentials; Mitochondria; Reactive Oxygen Species | 2001 |